We’re very proud of cooperating with a Hungarian start up company who is developing a medical device that will be able to predict if a newly diagnosed RA patient will react on methothrexate therapy or not. As large naïve patient populations exist in our country, our sites have been continuously delivering high numbers of rheumatoid arthritis patients. Cortex team also monitored studies in the osteoarthritis of the knee.